Ondine Biomedical Inc. (LON:OBI - Get Free Report) shot up 3.8% during trading on Monday . The company traded as high as C$14.00 and last traded at C$13.50. 373,028 shares were traded during mid-day trading, an increase of 46% from the average session volume of 254,635 shares. The stock had previously closed at C$13.00.
Ondine Biomedical Price Performance
The stock's 50-day simple moving average is C$13.15 and its 200 day simple moving average is C$11.09. The company has a quick ratio of 8.26, a current ratio of 1.36 and a debt-to-equity ratio of 25.95. The company has a market cap of C$109.04 million, a price-to-earnings ratio of -4.57 and a beta of 0.10.
About Ondine Biomedical
(
Get Free Report)
Ondine Biomedical is a life sciences company leading the charge in breakthrough photodisinfection-based therapies to prevent and treat serious infections, including those caused by existing, emerging, and antimicrobial-resistant pathogens.
Our vision is a world free from infections. We have created a patented, platform technology (photodisinfection) to provide simple solutions to complex infections across different therapeutic areas in healthcare and industry settings.
Read More
Before you consider Ondine Biomedical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ondine Biomedical wasn't on the list.
While Ondine Biomedical currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
